Evolving trends in liver transplantation: An outcome and charge analysis

Transplantation

Volumn 67, Issue 2, 1999, Pages 246-253

  Gilbert, Julie R ^a   Pascual, Manuel ^a   Schoenfeld, David A ^a   Rubin, Robert H ^a   Delmonico, Francis L ^a   Cosimi, A Benedict ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH ECONOMICS; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BOSTON; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; FEMALE; HUMANS; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; WAITING LISTS;

EID: 0033608077     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901270-00010     Document Type: Article

References (33)

1. Evans RW, Manninen DL, Dong RB. An economic analysis of liver transplantation: costs, insurance coverage, and reimbursement. Gastroenterol Clin North Am 1993; 22: 451.
2. UNOS. Critical data: weekly facts about transplantation for April 15, 1998 [http://www.unos.org/newsroom/critdata_main.htm]. United Network for Organ Sharing, 1998.
3. Harper AM, Rosendale. The UNOS OPTN waiting list and donor registry: 1988-1996. In: Cecka JM. Terasaki PI, eds. Clinical Transplants: 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1996; 69.
4. Steinbrook R. Allocating livers: devising a fair system. N Engl J Med 1997; 336: 436.
5. Bronsther O, Fung JJ, Izakis A, Van Thiel D, Starzl TE. Prioritization and organ distribution for liver transplantation. JAMA 1994; 271: 140.
6. Evans RW, Orians CE, Ascher NL. The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. JAMA 1992; 267: 239.
7. Kauffman HM, Bennett LE, McBride MA, Ellison MD. The expanded donor. Transplant Rev 1997; 11: 165.
8. Alexander JW, Zola JC. Expanding the donor pool: use of marginal donors for solid organ transplantation. Clin Transplant 1996; 10: 1.
9. Mirza DF, Gunson BK, Da Silva RF, Mayer AD, Buckels JA, McMaster P. Policies in Europe on "marginal quality" donor livers. Lancet 1994; 344: 1480.
10. United Network for Organ Sharing. 1997 Annual Report of the U.S. Scientific Registry of Transplant Patients and the Organ Procurement Transplantation Network. Richmond, VA: Department of Health and Human Services, 1997.
11. Washburn WK, Johnson LB, Lewis WD, Jenkins RL. Graft function and outcome of older (> or = 60 years) donor livers. Transplantation 1996; 61: 1062.
12. Morrisey M, Rustand L. Financial considerations in liver transplantation. In: Busuttil RW, Klintmalm GB, eds. Transplantation of the liver. Philadelphia: WB Saunders Co, 1996: 861.
13. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993; 56: 554.
14. Stratta RJ, Cushing KA, Frisbie K, Miller SA. Analysis of hospital charges after simultaneous pancreas-kidney transplantation in the era of managed care. Transplantation 1997; 64: 287.
15. Lake JR, Gorman KJ, Esquivel CO, et al. The impact of immunosuppressive regimens on the cost of liver transplantation: results from the U.S. FK506 multicenter trial. Transplantation 1995; 60: 1089.
16. Falagas ME, Arbo M, Ruthazer R, et al. Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients. Transplantation 1997; 63: 1595.
17. Cosimi AB. Update on liver transplantation. Transplant Proc 1991; 23: 2083.
18. Rubin RH. Infection in the organ transplant patient. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host, 3rd Ed. New York: Plenum Medical Book Co, 1994: 629.
19. Hibberd PL, Tolkoff-Rubin NE, Conti D, et al. Preemptive ganciclovir therapy to prevent Cytomegalovirus disease in cytomegalovirus-antibody positive renal transplant patients. Ann Intern Med 1995; 123: 18.
20. Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. In: Cecka JM, Terasaki PI, eds. Clinical Transplants: 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1996; 19.
21. Starzl TE, Todo S, Demetris AJ, Fung JJ. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis 1998; 31 (suppl 1): S7.
22. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
23. Nymann T, Shokouh-Amiri MH, Vera SR, Riely CA, Alloway RR, Gaber AO. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation. Clin Transplant 1996; 10; 663.
24. Ben-Ari Z, Shmueli D, Mor E, Shapira Z, Tur-Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997; 63: 393.
25. Tolkoff-Rubin NE, Rubin RH. The infectious disease problems of the diabetic renal transplant recipient. Inf Dis Clinics North Am 1995; 9: 117.
26. Rubin RH, Wolfson JS, Cosimi AB, et al. Infection in the renal transplant recipient. Am J Med 1981; 70: 405.
27. Hauboldt RH. Cost implications of human organ and tissue transplantations; an update: 1996. New York: Milliman & Robertson, Inc., 1996; 30.
28. Havel M, Owen AN, Simon P, et al. Decreasing use of donated blood and reduction of bleeding after orthotopic heart transplantation by use of aprotinin. J Heart Lung Transplant 1992; 11: 248.
29. Goodnough LT, Monk TG, Sicard G. et al. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: an analysis of cost and benefit. J Vasc Surg 1996; 24: 213.
30. Kemper RR, Menitove JE, Hanto DW. Cost analysis of intraoperative blood salvage during orthotopic liver transplantation. Liver Transplant Surg 1997; 3: 513.
31. Evans RW. Organ procurement and expenditures and the role of financial incentives. JAMA 1993; 269: 3113.
32. Eggers PW, Kucken LE. Cost issues in transplantation. Surg Clin North Am 1994; 74: 1259.
33. Evans RW. Cost-effectiveness analysis of transplantation. Surg Clin North Am 1986; 66: 603.